Literature DB >> 10385416

Growth hormone (GH) and prolactin receptors in human peripheral blood mononuclear cells: relation with age and GH-binding protein.

J L Bresson1, S Jeay, M C Gagnerault, C Kayser, N Beressi, Z Wu, S Kinet, M Dardenne, M C Postel-Vinay.   

Abstract

GH receptors (GHRs) and PRL receptors (PRLRs) were studied in human peripheral blood mononuclear cells (PBMC) using flow cytometry, biotinylated anti-GH receptor monoclonal antibody 10B8, and biotinylated human PRL. Variations of GHR and PRLR expression and the relationship of plasma GHBP and GH receptor in PBMC subsets were examined as a function of age and sex. By double immunofluorescence staining, we show that about 30% of total cells express GH receptors, with a low expression in T cells, whereas almost all B cells and monocytes are GH receptor positive. Four age groups were defined among the 64 normal volunteers, aged 12 to 85 yr, who were included in the study. The percentage of PBMC expressing GH receptors is significantly lower in group 2 (20-40 yr) than in group 1 (12-20 yr) and group 4 (>60 yr). In T cells, monocytes and B cells, no significant changes are detected in either the percentage of GH receptor positive cells or in the GH receptor level per cell. The level of PRLRs expressed in PBMC is significantly higher in age group 2 than in age group 4. A negative correlation is observed between plasma GHBP and the percentage of PBMC expressing GH receptors. These results suggest that regulation of GH receptors in lymphocytes and in other target cells could be different.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10385416     DOI: 10.1210/endo.140.7.6854

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  10 in total

1.  Long-term effects of growth hormone (GH) replacement therapy on hematopoiesis in a large cohort of children with GH deficiency.

Authors:  Andrea Esposito; Donatella Capalbo; Lucia De Martino; Martina Rezzuto; Raffaella Di Mase; Claudio Pignata; Mariacarolina Salerno
Journal:  Endocrine       Date:  2015-10-28       Impact factor: 3.633

2.  Prolactin levels, endothelial dysfunction, and the risk of cardiovascular events and mortality in patients with CKD.

Authors:  Juan Jesús Carrero; John Kyriazis; Alper Sonmez; Ioannis Tzanakis; Abdul Rashid Qureshi; Peter Stenvinkel; Mutlu Saglam; Kostas Stylianou; Halil Yaman; Abdullah Taslipinar; Abdulgaffar Vural; Mahmut Gok; Mujdat Yenicesu; Eugene Daphnis; Mahmut Ilker Yilmaz
Journal:  Clin J Am Soc Nephrol       Date:  2011-12-22       Impact factor: 8.237

3.  Growth Hormone Receptor Gene Expression Increase Reflects Nutritional Status Improvement in Patients Affected by Crohn's Disease.

Authors:  Sara Pagani; Elena Bozzola; Caterina Strisciuglio; Cristina Meazza; Erasmo Miele; M Malamisura; Paola De Angelis; Mauro Bozzola
Journal:  Front Pediatr       Date:  2018-11-12       Impact factor: 3.418

Review 4.  Rejuvenation of the aging T cell compartment.

Authors:  Amanda M Holland; Marcel R M van den Brink
Journal:  Curr Opin Immunol       Date:  2009-07-14       Impact factor: 7.486

5.  Growth Hormone Releasing Hormone in Endothelial Barrier Function.

Authors:  Nektarios Barabutis
Journal:  Trends Endocrinol Metab       Date:  2021-03-23       Impact factor: 10.586

6.  The Impact of Growth Hormone Therapy on the Apoptosis Assessment in CD34+ Hematopoietic Cells from Children with Growth Hormone Deficiency.

Authors:  Miłosz Piotr Kawa; Iwona Stecewicz; Katarzyna Piecyk; Edyta Paczkowska; Dorota Rogińska; Anna Sobuś; Karolina Łuczkowska; Ewa Pius-Sadowska; Elżbieta Gawrych; Elżbieta Petriczko; Mieczysław Walczak; Bogusław Machaliński
Journal:  Int J Mol Sci       Date:  2017-01-07       Impact factor: 5.923

7.  Immunological Profile and Predisposition to Autoimmunity in Girls With Turner Syndrome.

Authors:  Aneta Monika Gawlik; Elzbieta Berdej-Szczot; Dorota Blat; Renata Klekotka; Tomasz Gawlik; Ewa Blaszczyk; Magdalena Hankus; Ewa Malecka-Tendera
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-04       Impact factor: 5.555

8.  Recombinant human growth hormone and insulin-like growth factor-1 do not affect mitochondrial derived highly reactive oxygen species production in peripheral blood mononuclear cells under conditions of substrate saturation in-vitro.

Authors:  James Keane; Lotti Tajouri; Bon Gray
Journal:  Nutr Metab (Lond)       Date:  2016-07-04       Impact factor: 4.169

Review 9.  Why Should Growth Hormone (GH) Be Considered a Promising Therapeutic Agent for Arteriogenesis? Insights from the GHAS Trial.

Authors:  Diego Caicedo; Pablo Devesa; Clara V Alvarez; Jesús Devesa
Journal:  Cells       Date:  2020-03-27       Impact factor: 6.600

10.  Growth Hormone (GH) Deficient Mice With GHRH Gene Ablation Are Severely Deficient in Vaccine and Immune Responses Against Streptococcus pneumoniae.

Authors:  Khalil Farhat; Gwennaëlle Bodart; Chantal Charlet-Renard; Christophe J Desmet; Michel Moutschen; Yves Beguin; Frédéric Baron; Pierrette Melin; Pascale Quatresooz; Anne-Simone Parent; Daniel Desmecht; Jean-Claude Sirard; Roberto Salvatori; Henri Martens; Vincent G Geenen
Journal:  Front Immunol       Date:  2018-10-02       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.